397 - 408 of 7723 results
1 CME CREDIT

Thyroid: "Curbsiders"

1.00 CME/MOC
1.00 AANP | 0.40 Pharmacology


1.5 CME CREDITS

Geriatric Update: Cognitive Decline and Polypharmacy

1.50 CME/MOC
1.50 AANP | 0.75 Pharmacology

As we see more patients with cognitive impairment, understanding the real-world care for this population is vital. This lecture will review the most efficient means of assessing cognitive impairment, examine common issues in caring for the older adult with cognitive impairment, and discuss pharmacologic/non-pharmacologic means of treating patients. Dr. Lindquist will also address updates on what medications are useless/useful and what testing should be avoided. Polypharmacy is common among older adults and associated with adverse outcomes. This case-based session will review how to avoid inappropriate prescribing, recognize adverse drug events, and identify opportunities to deprescribe. Dr. Bradley will review recent literature updates that inform our prescribing practices including the 2019 AGS Beers criteria. Tips to enhance safe medication use will be shared. The updates will be followed by an “Ask the Expert” session with Drs. Lindquist and Bradley where they will review common questions and take questions from attendees.


1 CME CREDIT

During this informative session on medical literature updates (excluding COVID-19), primary care physician, Dr. Charles Vega, will review the clinical implications of practice-changing literature that has been recently published. Topics for discussion will include: breast cancer screening, colorectal cancer screening, association between diet/exercise and cancer, vaccination updates, dietary coconut oil, milk preference in children, personal protective equipment, COPD management, deprescribing in older adults, metformin in chronic kidney disease, and medication assisted treatment for opioid use disorder. You don’t want to miss these updates!


0.5 CME CREDIT

Hypercholesteremia is highly prevalent in the U.S. and strongly associated with cardiovascular morbidity and mortality. Yet, only about 55% of U.S. adults appropriate for cholesterol lowering therapy are currently taking it. What do primary care providers need to know to improve the care of the many individuals with hypercholesterolemia that you see daily in clinical practice? Join Dr. Ty Gluckman in this webcast to find out.


1 CME CREDIT

Introduction to Patient-Centered Clinical Care for African Americans

Episode 1: Bridging the Gap: Conversations with Dr. Hall

1.00 CME

In this session, Dr. Gregory Hall will provide a foundation of information including current statistics and demographics of African Americans’ health. He will review trust and bias issues as well as their origins in the history of healthcare of African Americans. Finally, he will provide some examples of important differences in the clinical care of African Americans as he sets the stage for more detailed discussion in future sessions of this monthly webcast. Dr. Hall is a Primary Care Physician and an expert in Black American Health and Healthcare. He is the former chair of the Ohio Commission on Minority Health, Director of the National Center for African American Health, Research, Education and Policy at Cleveland State University, and Author of “Patient-Centered Clinical Care for African Americans: A Concise, Evidence-Based Guide to Important Differences and Better Outcomes”. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 07/14/2021 and they are subject to change as new information is published.


0.5 CME CREDIT

Coronary artery calcium can be a valuable tool to measure cardiovascular risk and to inform the treatment of hyperlipidemia in appropriately selected individuals. Join Dr. Ty Gluckman as he discusses the history, predictive value, and most effective use of coronary artery calcium.


0.5 CME CREDIT

ver 500,000 Americans of all ages and increases the risk of mortality by 3-4 times that of the general public. Yet, primary care providers receive little training on the specific health risks that affect the homeless nor on how to evaluate and care for these individuals. Join Dr. Chuck Vega as he tackles this vital but oft overlooked topic from a primary care point of view.


1 CME CREDIT

This talk will cover the potential and the challenges in genetic discovery that need to be met in order to support the utility of genomics in clinical care. Genome methods including whole genome sequencing will be covered. The successes in pediatric genetics will be contrasted with the greater challenges in adult medicine.


1 CME CREDIT

Updates on Cancer Screening

1.00 CME/MOC
1.00 AANP

The early detection of cancer can significantly improve the treatment and outcomes for patients. Screening is an effective tool for early detection, but emerging evidence constantly shift these recommendations. This case-based presentation will focus on the most recent guidelines from the leading agencies including ACS, NCCN, and USPSTF and discuss strategies on how to apply them to your patients.


0.5 CME CREDIT

COVID-19: Ask the ID Expert

0.50 CME/MOC
0.50 AANP

These troubling times require communication among specialists and primary care. In this COVID-19 ask the expert the faculty will discuss the most pressing and frequently asked questions about this disease and its complications.


0.5 CME CREDIT

Join Dr. Ty Gluckman as he dives deeper into the treatment of atrial fibrillation. This program will focus on rate and rhythm control and the pivotal role they play in alleviating symptoms of AF. Dr. Gluckman will discuss factors that would guide clinical decision making towards a strategy that focuses on rate vs rhythm control.


1 CME CREDIT

Updates on Asthma and COPD

1.00 CME/MOC
1.00 AANP | 0.50 Pharmacology

Asthma & chronic obstructive pulmonary disease (COPD) can have overlapping symptoms, but they are characterized by different pathogenic mechanisms and different responses to anti-inflammatory therapies. Dozens of medications and interventions have been approved and prescribed to combat these diseases, and treatments strategies have been developed that depend largely on severity of symptoms. But how should we approach these patients? What’s new in asthma and COPD? This case-based presentation will help you review what you need to know about asthma and COPD in 2020.